01
Industrial Production of oral dosages forms
02
Analytical development and validation
03
Development of pharmaceutical formulations (including modified released forms)
04
Scaling up
05
Process development and validation
06
QC analysis and release
07
Packaging of pharmaceutical oral dosages forms in blisters and/or bottles
08
Registration via National submission or DCP procedure
09
Direct marketing in selected Countries
The factory is focused on the manufacture and packaging of tablet and capsule oral solid dosage forms and has been inspected and approved by the Swiss Authorities and by the FDA. We also welcome the regular audits carried out by our customers in order to confirm that our high quality standards satisfy their requirements.
Developharma is the sister company to Rivopharm. Developharma provides pharmaceutical development services to Rivopharm as well a to third party pharmaceutical companies, either on an exclusive basis or as possible joint development project. An essential success factor is the long-term experience and high degree of expertise in the group coupled with the application of moderntechnologies tooptimise proven products. Developharma is able to provide a full in- house service where product development is concerned.
In addition to producing products coming from its R&D, Rivopharm offers to its customers the possibility of contract manufacture of their own product formulations. Our scientists have particular expertise in a wide range of oral dosage forms from the conventional to advanced and complex technologies. Thanks to our company’s flexibility it is possible to follow an efficient product development program and to satisfy any demand.
Our regulatory affairs department is of primary importance to our success. they are the main communications link between the company and the various regulatory agencies and are responsible for keeping up with the increasing scope and complexity of regulations in world markets. one of the company’s strengths is the ability to offer a “full package” support service. In order to meet the exacting needs of our customers, we are continually strengthening our regulatory group to provide an efficient and high quality service.
In cooperation with our partners, the department advises and coordinates the approval and registration of our out-licensed products in order to minimise “time to market”.
© 2018, Rivopharm. All Rights Reserved. Terms of Use Privacy Policy
Follow us on:
